WEED, Inc.
WEED, Inc. (BUDZ) Stock Competitors & Peer Comparison
See (BUDZ) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BUDZ | $0.02 | -9.09% | 2.7M | -2.00 | -$0.01 | N/A |
| IPSEY | $44.01 | +3.00% | 58B | 28.47 | $1.54 | +0.91% |
| TKPHF | $35.00 | +2.79% | 55.3B | 79.55 | $0.44 | +3.78% |
| MKGAF | $127.76 | +1.30% | 55.2B | 18.31 | $6.94 | +2.11% |
| MKKGY | $24.36 | +1.33% | 53B | 17.55 | $1.39 | +2.05% |
| HLNCF | $4.92 | +1.23% | 43.8B | 19.68 | $0.25 | +1.86% |
| SDZNY | $75.58 | +0.06% | 32.7B | 36.16 | $2.09 | +0.96% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $23.60 | +10.02% | 20.1B | 18.73 | $1.26 | +1.87% |
| SGIOY | $10.87 | +1.87% | 18.5B | 17.27 | $0.63 | +1.85% |
Stock Comparison
BUDZ vs IPSEY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, IPSEY has a market cap of 58B. Regarding current trading prices, BUDZ is priced at $0.02, while IPSEY trades at $44.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas IPSEY's P/E ratio is 28.47. In terms of profitability, BUDZ's ROE is +1.97%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, BUDZ and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
BUDZ vs TKPHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, TKPHF has a market cap of 55.3B. Regarding current trading prices, BUDZ is priced at $0.02, while TKPHF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas TKPHF's P/E ratio is 79.55. In terms of profitability, BUDZ's ROE is +1.97%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, BUDZ is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check TKPHF's competition here
BUDZ vs MKGAF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, MKGAF has a market cap of 55.2B. Regarding current trading prices, BUDZ is priced at $0.02, while MKGAF trades at $127.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas MKGAF's P/E ratio is 18.31. In terms of profitability, BUDZ's ROE is +1.97%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, BUDZ is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check MKGAF's competition here
BUDZ vs MKKGY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, MKKGY has a market cap of 53B. Regarding current trading prices, BUDZ is priced at $0.02, while MKKGY trades at $24.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas MKKGY's P/E ratio is 17.55. In terms of profitability, BUDZ's ROE is +1.97%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, BUDZ is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check MKKGY's competition here
BUDZ vs HLNCF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HLNCF has a market cap of 43.8B. Regarding current trading prices, BUDZ is priced at $0.02, while HLNCF trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HLNCF's P/E ratio is 19.68. In terms of profitability, BUDZ's ROE is +1.97%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, BUDZ is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check HLNCF's competition here
BUDZ vs SDZNY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SDZNY has a market cap of 32.7B. Regarding current trading prices, BUDZ is priced at $0.02, while SDZNY trades at $75.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SDZNY's P/E ratio is 36.16. In terms of profitability, BUDZ's ROE is +1.97%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, BUDZ is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check SDZNY's competition here
BUDZ vs TEVJF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, BUDZ is priced at $0.02, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, BUDZ's ROE is +1.97%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, BUDZ and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
BUDZ vs SGIOF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SGIOF has a market cap of 20.1B. Regarding current trading prices, BUDZ is priced at $0.02, while SGIOF trades at $23.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SGIOF's P/E ratio is 18.73. In terms of profitability, BUDZ's ROE is +1.97%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, BUDZ and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
BUDZ vs SGIOY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SGIOY has a market cap of 18.5B. Regarding current trading prices, BUDZ is priced at $0.02, while SGIOY trades at $10.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SGIOY's P/E ratio is 17.27. In terms of profitability, BUDZ's ROE is +1.97%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, BUDZ is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check SGIOY's competition here
BUDZ vs TAIPY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, BUDZ is priced at $0.02, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, BUDZ's ROE is +1.97%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, BUDZ is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check TAIPY's competition here
BUDZ vs ESALY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, BUDZ is priced at $0.02, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ESALY's P/E ratio is 20.54. In terms of profitability, BUDZ's ROE is +1.97%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, BUDZ is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check ESALY's competition here
BUDZ vs BIOVF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, BIOVF has a market cap of 14.3B. Regarding current trading prices, BUDZ is priced at $0.02, while BIOVF trades at $41.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas BIOVF's P/E ratio is 295.14. In terms of profitability, BUDZ's ROE is +1.97%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, BUDZ and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
BUDZ vs IPSEF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, BUDZ is priced at $0.02, while IPSEF trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas IPSEF's P/E ratio is 18.79. In terms of profitability, BUDZ's ROE is +1.97%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, BUDZ is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check IPSEF's competition here
BUDZ vs ESALF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ESALF has a market cap of 9.3B. Regarding current trading prices, BUDZ is priced at $0.02, while ESALF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ESALF's P/E ratio is 30.00. In terms of profitability, BUDZ's ROE is +1.97%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, BUDZ and ESALF have similar daily volatility (0.00).Check ESALF's competition here
BUDZ vs ESAIY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ESAIY has a market cap of 8.8B. Regarding current trading prices, BUDZ is priced at $0.02, while ESAIY trades at $7.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ESAIY's P/E ratio is 28.58. In terms of profitability, BUDZ's ROE is +1.97%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, BUDZ is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check ESAIY's competition here
BUDZ vs SFOSF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SFOSF has a market cap of 7.1B. Regarding current trading prices, BUDZ is priced at $0.02, while SFOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SFOSF's P/E ratio is 15.00. In terms of profitability, BUDZ's ROE is +1.97%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, BUDZ is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check SFOSF's competition here
BUDZ vs GZPHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, BUDZ is priced at $0.02, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, BUDZ's ROE is +1.97%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, BUDZ and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
BUDZ vs HLUBF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HLUBF has a market cap of 5.3B. Regarding current trading prices, BUDZ is priced at $0.02, while HLUBF trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HLUBF's P/E ratio is 10.74. In terms of profitability, BUDZ's ROE is +1.97%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, BUDZ and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
BUDZ vs LVZPF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, LVZPF has a market cap of 5.1B. Regarding current trading prices, BUDZ is priced at $0.02, while LVZPF trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas LVZPF's P/E ratio is 12.79. In terms of profitability, BUDZ's ROE is +1.97%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, BUDZ and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
BUDZ vs DNPUF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, DNPUF has a market cap of 4.6B. Regarding current trading prices, BUDZ is priced at $0.02, while DNPUF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas DNPUF's P/E ratio is 4.75. In terms of profitability, BUDZ's ROE is +1.97%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, BUDZ and DNPUF have similar daily volatility (0.00).Check DNPUF's competition here
BUDZ vs HLBBF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HLBBF has a market cap of 4.5B. Regarding current trading prices, BUDZ is priced at $0.02, while HLBBF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HLBBF's P/E ratio is 11.18. In terms of profitability, BUDZ's ROE is +1.97%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, BUDZ and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
BUDZ vs SMDPY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SMDPY has a market cap of 4.5B. Regarding current trading prices, BUDZ is priced at $0.02, while SMDPY trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SMDPY's P/E ratio is 4.61. In terms of profitability, BUDZ's ROE is +1.97%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, BUDZ and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
BUDZ vs SGFEF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, BUDZ is priced at $0.02, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SGFEF's P/E ratio is 20.62. In terms of profitability, BUDZ's ROE is +1.97%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, BUDZ is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check SGFEF's competition here
BUDZ vs HKMPY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HKMPY has a market cap of 3.7B. Regarding current trading prices, BUDZ is priced at $0.02, while HKMPY trades at $33.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HKMPY's P/E ratio is 9.18. In terms of profitability, BUDZ's ROE is +1.97%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, BUDZ and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
BUDZ vs HKMPF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HKMPF has a market cap of 3.6B. Regarding current trading prices, BUDZ is priced at $0.02, while HKMPF trades at $16.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HKMPF's P/E ratio is 9.06. In terms of profitability, BUDZ's ROE is +1.97%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, BUDZ and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
BUDZ vs APNHY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, APNHY has a market cap of 3.4B. Regarding current trading prices, BUDZ is priced at $0.02, while APNHY trades at $7.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas APNHY's P/E ratio is -31.54. In terms of profitability, BUDZ's ROE is +1.97%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, BUDZ and APNHY have similar daily volatility (0.00).Check APNHY's competition here
BUDZ vs LBTSF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, BUDZ is priced at $0.02, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas LBTSF's P/E ratio is 61.40. In terms of profitability, BUDZ's ROE is +1.97%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, BUDZ and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
BUDZ vs APNHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, BUDZ is priced at $0.02, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas APNHF's P/E ratio is -30.21. In terms of profitability, BUDZ's ROE is +1.97%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, BUDZ and APNHF have similar daily volatility (0.00).Check APNHF's competition here
BUDZ vs INVVY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, BUDZ is priced at $0.02, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas INVVY's P/E ratio is -62.42. In terms of profitability, BUDZ's ROE is +1.97%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, BUDZ and INVVY have similar daily volatility (0.00).Check INVVY's competition here
BUDZ vs HYPMY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, BUDZ is priced at $0.02, while HYPMY trades at $4.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HYPMY's P/E ratio is 12.18. In terms of profitability, BUDZ's ROE is +1.97%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, BUDZ is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check HYPMY's competition here
BUDZ vs IZQVF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, BUDZ is priced at $0.02, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, BUDZ's ROE is +1.97%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, BUDZ and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
BUDZ vs HMDCF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, BUDZ is priced at $0.02, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HMDCF's P/E ratio is 5.47. In terms of profitability, BUDZ's ROE is +1.97%, compared to HMDCF's ROE of +0.42%. Regarding short-term risk, BUDZ is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check HMDCF's competition here
BUDZ vs NPPNY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, BUDZ is priced at $0.02, while NPPNY trades at $7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas NPPNY's P/E ratio is 11.77. In terms of profitability, BUDZ's ROE is +1.97%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, BUDZ and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
BUDZ vs ULIHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ULIHF has a market cap of 2.3B. Regarding current trading prices, BUDZ is priced at $0.02, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ULIHF's P/E ratio is 7.34. In terms of profitability, BUDZ's ROE is +1.97%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, BUDZ is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check ULIHF's competition here
BUDZ vs CHSYF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CHSYF has a market cap of 2.3B. Regarding current trading prices, BUDZ is priced at $0.02, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CHSYF's P/E ratio is 9.31. In terms of profitability, BUDZ's ROE is +1.97%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, BUDZ and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
BUDZ vs NPNKF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, BUDZ is priced at $0.02, while NPNKF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas NPNKF's P/E ratio is 10.77. In terms of profitability, BUDZ's ROE is +1.97%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, BUDZ and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
BUDZ vs DMPHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, BUDZ is priced at $0.02, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, BUDZ's ROE is +1.97%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, BUDZ is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check DMPHF's competition here
BUDZ vs TSMRF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, BUDZ is priced at $0.02, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas TSMRF's P/E ratio is 12.19. In terms of profitability, BUDZ's ROE is +1.97%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, BUDZ and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
BUDZ vs HTSUF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, BUDZ is priced at $0.02, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, BUDZ's ROE is +1.97%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, BUDZ and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
BUDZ vs ARSUF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, BUDZ is priced at $0.02, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ARSUF's P/E ratio is 18.88. In terms of profitability, BUDZ's ROE is +1.97%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, BUDZ and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
BUDZ vs DUTV Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, BUDZ is priced at $0.02, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas DUTV's P/E ratio is N/A. In terms of profitability, BUDZ's ROE is +1.97%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, BUDZ is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check DUTV's competition here
BUDZ vs SHPHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, BUDZ is priced at $0.02, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, BUDZ's ROE is +1.97%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, BUDZ and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
BUDZ vs MITPF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, BUDZ is priced at $0.02, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas MITPF's P/E ratio is -10.81. In terms of profitability, BUDZ's ROE is +1.97%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, BUDZ is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check MITPF's competition here
BUDZ vs KARBF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, BUDZ is priced at $0.02, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas KARBF's P/E ratio is 262.50. In terms of profitability, BUDZ's ROE is +1.97%, compared to KARBF's ROE of N/A. Regarding short-term risk, BUDZ and KARBF have similar daily volatility (0.00).Check KARBF's competition here
BUDZ vs CURLF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CURLF has a market cap of 1.5B. Regarding current trading prices, BUDZ is priced at $0.02, while CURLF trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CURLF's P/E ratio is -5.91. In terms of profitability, BUDZ's ROE is +1.97%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, BUDZ is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check CURLF's competition here
BUDZ vs CASBF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CASBF has a market cap of 1.4B. Regarding current trading prices, BUDZ is priced at $0.02, while CASBF trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CASBF's P/E ratio is -39.70. In terms of profitability, BUDZ's ROE is +1.97%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, BUDZ is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check CASBF's competition here
BUDZ vs CHIZF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, BUDZ is priced at $0.02, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, BUDZ's ROE is +1.97%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, BUDZ and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
BUDZ vs GTBIF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, GTBIF has a market cap of 1.3B. Regarding current trading prices, BUDZ is priced at $0.02, while GTBIF trades at $5.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas GTBIF's P/E ratio is 11.74. In terms of profitability, BUDZ's ROE is +1.97%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, BUDZ is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check GTBIF's competition here
BUDZ vs SWGHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, BUDZ is priced at $0.02, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, BUDZ's ROE is +1.97%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, BUDZ and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
BUDZ vs KSPHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, BUDZ is priced at $0.02, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas KSPHF's P/E ratio is 14.08. In terms of profitability, BUDZ's ROE is +1.97%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, BUDZ and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
BUDZ vs EVOTF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, EVOTF has a market cap of 1.3B. Regarding current trading prices, BUDZ is priced at $0.02, while EVOTF trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas EVOTF's P/E ratio is -6.78. In terms of profitability, BUDZ's ROE is +1.97%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, BUDZ and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
BUDZ vs TWAPF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, BUDZ is priced at $0.02, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, BUDZ's ROE is +1.97%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, BUDZ and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
BUDZ vs LJUIF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, BUDZ is priced at $0.02, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, BUDZ's ROE is +1.97%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, BUDZ is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check LJUIF's competition here
BUDZ vs BIOGY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, BUDZ is priced at $0.02, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, BUDZ's ROE is +1.97%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, BUDZ and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
BUDZ vs SHEZF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SHEZF has a market cap of 1.1B. Regarding current trading prices, BUDZ is priced at $0.02, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, BUDZ's ROE is +1.97%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, BUDZ and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
BUDZ vs TCNNF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, TCNNF has a market cap of 1B. Regarding current trading prices, BUDZ is priced at $0.02, while TCNNF trades at $5.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas TCNNF's P/E ratio is -9.18. In terms of profitability, BUDZ's ROE is +1.97%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, BUDZ is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check TCNNF's competition here
BUDZ vs KKPCF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, BUDZ is priced at $0.02, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas KKPCF's P/E ratio is 297.56. In terms of profitability, BUDZ's ROE is +1.97%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, BUDZ is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check KKPCF's competition here
BUDZ vs GNMLF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, GNMLF has a market cap of 886.9M. Regarding current trading prices, BUDZ is priced at $0.02, while GNMLF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas GNMLF's P/E ratio is 10.12. In terms of profitability, BUDZ's ROE is +1.97%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, BUDZ is less volatile compared to GNMLF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check GNMLF's competition here
BUDZ vs CSWYF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, BUDZ is priced at $0.02, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, BUDZ's ROE is +1.97%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, BUDZ is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check CSWYF's competition here
BUDZ vs NIKA Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, BUDZ is priced at $0.02, while NIKA trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas NIKA's P/E ratio is N/A. In terms of profitability, BUDZ's ROE is +1.97%, compared to NIKA's ROE of +0.29%. Regarding short-term risk, BUDZ and NIKA have similar daily volatility (0.00).Check NIKA's competition here
BUDZ vs TRXPF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, BUDZ is priced at $0.02, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, BUDZ's ROE is +1.97%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, BUDZ and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
BUDZ vs YIHCF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, BUDZ is priced at $0.02, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, BUDZ's ROE is +1.97%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, BUDZ and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
BUDZ vs AIHLF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, BUDZ is priced at $0.02, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, BUDZ's ROE is +1.97%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, BUDZ and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
BUDZ vs TRSSF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, BUDZ is priced at $0.02, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, BUDZ's ROE is +1.97%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, BUDZ is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check TRSSF's competition here
BUDZ vs GLASF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, GLASF has a market cap of 597M. Regarding current trading prices, BUDZ is priced at $0.02, while GLASF trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas GLASF's P/E ratio is -14.02. In terms of profitability, BUDZ's ROE is +1.97%, compared to GLASF's ROE of -0.23%. Regarding short-term risk, BUDZ is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check GLASF's competition here
BUDZ vs PKBFF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, BUDZ is priced at $0.02, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas PKBFF's P/E ratio is N/A. In terms of profitability, BUDZ's ROE is +1.97%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, BUDZ and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
BUDZ vs CCHWF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, BUDZ is priced at $0.02, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, BUDZ's ROE is +1.97%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, BUDZ is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check CCHWF's competition here
BUDZ vs BOIRF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, BUDZ is priced at $0.02, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, BUDZ's ROE is +1.97%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, BUDZ and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
BUDZ vs KHTRF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, KHTRF has a market cap of 518.6M. Regarding current trading prices, BUDZ is priced at $0.02, while KHTRF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas KHTRF's P/E ratio is -132.25. In terms of profitability, BUDZ's ROE is +1.97%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, BUDZ and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
BUDZ vs AGYTF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, BUDZ is priced at $0.02, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, BUDZ's ROE is +1.97%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, BUDZ and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
BUDZ vs PEXXF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, BUDZ is priced at $0.02, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, BUDZ's ROE is +1.97%, compared to PEXXF's ROE of N/A. Regarding short-term risk, BUDZ and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
BUDZ vs HUMDF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HUMDF has a market cap of 405.4M. Regarding current trading prices, BUDZ is priced at $0.02, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HUMDF's P/E ratio is 2.57. In terms of profitability, BUDZ's ROE is +1.97%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, BUDZ and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
BUDZ vs SWDCF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SWDCF has a market cap of 399.6M. Regarding current trading prices, BUDZ is priced at $0.02, while SWDCF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SWDCF's P/E ratio is 62.50. In terms of profitability, BUDZ's ROE is +1.97%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, BUDZ and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
BUDZ vs ELTP Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ELTP has a market cap of 393.1M. Regarding current trading prices, BUDZ is priced at $0.02, while ELTP trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ELTP's P/E ratio is 9.13. In terms of profitability, BUDZ's ROE is +1.97%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, BUDZ is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check ELTP's competition here
BUDZ vs VRNOF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, VRNOF has a market cap of 365.4M. Regarding current trading prices, BUDZ is priced at $0.02, while VRNOF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas VRNOF's P/E ratio is -1.02. In terms of profitability, BUDZ's ROE is +1.97%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, BUDZ is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check VRNOF's competition here
BUDZ vs CPHRF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CPHRF has a market cap of 334.8M. Regarding current trading prices, BUDZ is priced at $0.02, while CPHRF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CPHRF's P/E ratio is 12.55. In terms of profitability, BUDZ's ROE is +1.97%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, BUDZ is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check CPHRF's competition here
BUDZ vs CRLBF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CRLBF has a market cap of 274.6M. Regarding current trading prices, BUDZ is priced at $0.02, while CRLBF trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CRLBF's P/E ratio is -2.11. In terms of profitability, BUDZ's ROE is +1.97%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, BUDZ is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check CRLBF's competition here
BUDZ vs BHCCF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, BUDZ is priced at $0.02, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, BUDZ's ROE is +1.97%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, BUDZ is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check BHCCF's competition here
BUDZ vs PLNHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, BUDZ is priced at $0.02, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, BUDZ's ROE is +1.97%, compared to PLNHF's ROE of +659479.06%. Regarding short-term risk, BUDZ is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check PLNHF's competition here
BUDZ vs PHCUF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, BUDZ is priced at $0.02, while PHCUF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas PHCUF's P/E ratio is -700.00. In terms of profitability, BUDZ's ROE is +1.97%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, BUDZ and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
BUDZ vs COPHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, BUDZ is priced at $0.02, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas COPHF's P/E ratio is -0.02. In terms of profitability, BUDZ's ROE is +1.97%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, BUDZ is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check COPHF's competition here
BUDZ vs CBWTF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CBWTF has a market cap of 128.6M. Regarding current trading prices, BUDZ is priced at $0.02, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CBWTF's P/E ratio is 4.77. In terms of profitability, BUDZ's ROE is +1.97%, compared to CBWTF's ROE of +0.27%. Regarding short-term risk, BUDZ is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check CBWTF's competition here
BUDZ vs LOVFF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, LOVFF has a market cap of 124.5M. Regarding current trading prices, BUDZ is priced at $0.02, while LOVFF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas LOVFF's P/E ratio is 14.44. In terms of profitability, BUDZ's ROE is +1.97%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, BUDZ and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
BUDZ vs NWPN Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, BUDZ is priced at $0.02, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas NWPN's P/E ratio is -0.04. In terms of profitability, BUDZ's ROE is +1.97%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, BUDZ is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check NWPN's competition here
BUDZ vs BIOYF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, BIOYF has a market cap of 120.1M. Regarding current trading prices, BUDZ is priced at $0.02, while BIOYF trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas BIOYF's P/E ratio is 18.33. In terms of profitability, BUDZ's ROE is +1.97%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, BUDZ is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check BIOYF's competition here
BUDZ vs SHIEF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, SHIEF has a market cap of 114.7M. Regarding current trading prices, BUDZ is priced at $0.02, while SHIEF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas SHIEF's P/E ratio is -5.37. In terms of profitability, BUDZ's ROE is +1.97%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, BUDZ is less volatile compared to SHIEF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check SHIEF's competition here
BUDZ vs LPCUF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, BUDZ is priced at $0.02, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas LPCUF's P/E ratio is 9.41. In terms of profitability, BUDZ's ROE is +1.97%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, BUDZ is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check LPCUF's competition here
BUDZ vs CNVCF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, BUDZ is priced at $0.02, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, BUDZ's ROE is +1.97%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, BUDZ and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
BUDZ vs HLTRF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, HLTRF has a market cap of 107.6M. Regarding current trading prices, BUDZ is priced at $0.02, while HLTRF trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas HLTRF's P/E ratio is -8.82. In terms of profitability, BUDZ's ROE is +1.97%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, BUDZ is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check HLTRF's competition here
BUDZ vs CWBHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, CWBHF has a market cap of 104.2M. Regarding current trading prices, BUDZ is priced at $0.02, while CWBHF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas CWBHF's P/E ratio is -4.67. In terms of profitability, BUDZ's ROE is +1.97%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, BUDZ is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check CWBHF's competition here
BUDZ vs ORXOF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ORXOF has a market cap of 100.6M. Regarding current trading prices, BUDZ is priced at $0.02, while ORXOF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ORXOF's P/E ratio is -2.34. In terms of profitability, BUDZ's ROE is +1.97%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, BUDZ and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
BUDZ vs ORXOY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, BUDZ is priced at $0.02, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ORXOY's P/E ratio is -2.26. In terms of profitability, BUDZ's ROE is +1.97%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, BUDZ and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here
BUDZ vs ABSCF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, BUDZ is priced at $0.02, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas ABSCF's P/E ratio is -8.53. In terms of profitability, BUDZ's ROE is +1.97%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, BUDZ is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check ABSCF's competition here
BUDZ vs AAWH Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, AAWH has a market cap of 86.9M. Regarding current trading prices, BUDZ is priced at $0.02, while AAWH trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas AAWH's P/E ratio is -0.74. In terms of profitability, BUDZ's ROE is +1.97%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, BUDZ is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check AAWH's competition here
BUDZ vs JUSHF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, JUSHF has a market cap of 86.5M. Regarding current trading prices, BUDZ is priced at $0.02, while JUSHF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas JUSHF's P/E ratio is -1.33. In terms of profitability, BUDZ's ROE is +1.97%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, BUDZ is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check JUSHF's competition here
BUDZ vs EOFBY Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, BUDZ is priced at $0.02, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, BUDZ's ROE is +1.97%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, BUDZ and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
BUDZ vs GRUSF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, GRUSF has a market cap of 70.1M. Regarding current trading prices, BUDZ is priced at $0.02, while GRUSF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas GRUSF's P/E ratio is 9.37. In terms of profitability, BUDZ's ROE is +1.97%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, BUDZ is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check GRUSF's competition here
BUDZ vs MEDXF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, MEDXF has a market cap of 69.4M. Regarding current trading prices, BUDZ is priced at $0.02, while MEDXF trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas MEDXF's P/E ratio is -107.50. In terms of profitability, BUDZ's ROE is +1.97%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, BUDZ is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for BUDZ.Check MEDXF's competition here
BUDZ vs GDNSF Comparison April 2026
BUDZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BUDZ stands at 2.7M. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, BUDZ is priced at $0.02, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BUDZ currently has a P/E ratio of -2.00, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, BUDZ's ROE is +1.97%, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, BUDZ and GDNSF have similar daily volatility (0.00).Check GDNSF's competition here